S'abonner

Association between Type 2 Diabetes onset age and risk of cardiovascular disease and mortality: Two cohort studies from United Kingdom and Hong Kong - 30/01/25

Doi : 10.1016/j.diabet.2025.101607 
Boyuan Wang a, 1, Ivy Lynn Mak a, 1, Kiki Sze Nga Liu a, Edmond Pui Hang Choi b, Cindy Lo Kuen Lam a, c, Eric Yuk Fai Wan a, d, e,
a Department of Family Medicine and Primary Care, the University of Hong Kong, Hong Kong, China 
b School of Nursing, LKS Faculty of Medicine, the University of Hong Kong, Hong Kong, China 
c The University of Hong Kong-Shenzhen Hospital, Shenzhen, China 
d Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, the University of Hong Kong, Hong Kong, China 
e Advanced Data Analytics for Medical Science (ADAMS) Limited, Hong Kong, China 

Corresponding author at: Dr. Eric Yuk Fai Wan, Postal Address: Department of Family Medicine and Primary Care, the University of Hong Kong, 3/F Ap Lei Chau Clinic, 161 Main Street, Ap Lei Chau, Hong Kong.Department of Family Medicine and Primary Carethe University of Hong Kong3/F Ap Lei Chau Clinic, 161 Main Street, Ap Lei ChauHong Kong

Highlights

There is limited evidence to evaluate the CVD and mortality risk between people with and without diabetes in particular for young age group, this study aims to evaluate the effects of young T2DM onset on CVD and mortality risk.
Our study highlights the importance of prevention of T2DM and pre-T2DM in young adults, and the urge for stringent control of the T2DM and co-existing CVD risk factors for young T2DM patients.

Le texte complet de cet article est disponible en PDF.

Abstract

Objective

This study aimed to evaluate the association between type 2 diabetes mellitus (T2DM) onset age and risk of cardiovascular disease (CVD) and mortality.

Method

Two retrospective cohort studies were conducted using the electronic health records from the United Kingdom (UK) and Hong Kong (HK) on adults without CVD. During 2008-2013, 128,918 and 185,646 patients with new-onset T2DM were assigned to the T2DM group, and 5,052,770 and 3,159,396 patients without T2DM were included as controls in the UK and HK cohort, respectively. Patients were stratified into six age groups. Multivariable Cox regression, adjusted for baseline characteristics and fine stratification weights, was used to estimate the hazard ratios (HRs) and 95 % confidence intervals (CIs) for each outcome.

Results

New-onset T2DM was associated with increased CVD and mortality risk, but the risks decreased with age. Compared to those without T2DM in the same age groups, the HR (95 % CI) for CVD in the UK cohort was 3.22 (2.80, 3.71), 1.21 (1.15, 1.26), and 0.99 (0.93, 1.05) for T2DM individuals at ages 18–39, 60–69, and ≥ 80, respectively. Similarly, the HR (95 % CI) for mortality among new-onset T2DM patients was 2.41 (2.06, 2.83) for age 18–39, 1.40 (1.34, 1.46) for age 60–69, and 1.12 (1.08, 1.16) for age ≥ 80. Results from the HK cohort showed a similar pattern.

Conclusion

Young onset of T2DM is associated with a significant impact on cardiovascular health later in life. This highlights the importance of the prevention of DM in young adults.

Le texte complet de cet article est disponible en PDF.

Keywords : Type 2 diabetes mellitus (T2DM), Cardiovascular disease (CVD), Onset age of disease, Cohort study


Plan


© 2025  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 51 - N° 2

Article 101607- mars 2025 Retour au numéro
Article précédent Article précédent
  • Weight loss therapy and addiction: Increased risk after bariatric surgery but reduced risk with GLP-1 receptor agonists
  • André J. Scheen
| Article suivant Article suivant
  • New users of sodium-glucose cotransporter 2 inhibitors are at low risk of incident pancreatic cancer: A nationwide population-based cohort study
  • Yun Kyung Cho, Sehee Kim, Myung Jin Kim, Woo Je Lee, Ye-Jee Kim, Chang Hee Jung

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.